Pharmacogenetics of asthma
- 1 January 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pulmonary Medicine
- Vol. 15 (1), 57-62
- https://doi.org/10.1097/mcp.0b013e32831da8be
Abstract
Purpose of review Patient response to the asthma drug classes, bronchodilators, inhaled corticosteroids and leukotriene modifiers, are characterized by a large degree of heterogeneity, which is attributable in part to genetic variation. Herein, we review and update the pharmacogenetics and pharmaogenomics of common asthma drugs. Recent findings Early studies suggest that bronchodilator reversibility and asthma worsening in patients on continuous short-acting and long-acting β-agonists are related to the Gly16Arg genotype for the ADRB2. More recent studies including genome-wide association studies implicate variants in other genes contribute to bronchodilator response heterogeneity and fail to replicate asthma worsening associated with continuous β-agonist use. Genetic determinants of the safety of long-acting β-agonist require further study. Variants in CRHR1, TBX21, and FCER2 contribute to variability in response for lung function, airways responsiveness, and exacerbations in patients taking inhaled corticosteroids. Variants in ALOX5, LTA4H, LTC4S, ABCC1, CYSLTR2, and SLCO2B1 contribute to variability in response to leukotriene modifiers. Summary Identification of novel variants that contribute to response heterogeneity supports future studies of single nucleotide polymorphism discovery and include gene expression and genome-wide association studies. Statistical models that predict the genomics of response to asthma drugs will complement single nucleotide polymorphism discovery in moving toward personalized medicine.Keywords
This publication has 57 references indexed in Scilit:
- ARG1 Is a Novel Bronchodilator Response GeneAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthmaPharmacogenetics and Genomics, 2008
- Environmental Epigenetics and AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- LeukotrienesNew England Journal of Medicine, 2007
- Sequence, Haplotype, and Association Analysis ofADRβ2in a Multiethnic Asthma Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Eicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue ResponsesPharmacological Reviews, 2006
- β2-Adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmaticsHuman Genetics, 2006
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialThe Lancet, 2004
- Asthma control during long term treatment with regular inhaled salbutamol and salmeterolThorax, 1998
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996